Abstract
Introduction Acute ischemic stroke is a major subtype of acute stroke. More than 65% of stroke-related deaths occur in developing countries. Various modifiable and non-modifiable risk factors are associated with the stroke. TOAST classification categorizes ischemic stroke into five etiologic subgroups.
Aims To identify subtypes of acute ischemic stroke and compare the influence of various risk factors on them.
Methodology A prospective observational study was conducted in a tertiary care teaching hospital. 200 consecutive patients diagnosed as having acute ischemic stroke were randomly enrolled. Patients were categorized into 3 groups-Group A: 18-39 years (17%); Group B: 40-60 years (20%) and Group C: >60 years (63%). Stroke subtypes were ascertained using TOAST classification. Data analysis was done. For categorical variables, data values were represented as numbers and percentages. A chi-square test was applied to find the level of significance. p value<0.05 was considered significant.
Results The study included 136 men and 64 women. Overall male dominance (Male: Female = 2.125:1), while in Group A, strong female dominance (Male: Female = 1:4.67) was observed. The commonest subtype was embolism (29.4%) in Group A, and small vessel disease in Group B, and C ((30% & 46.03% respectively). Hypertension was the commonest risk factor (62%). A higher incidence of hypertension was found in Group A (73.02%, p = 0.002), dyslipidemia in Group B (45%, p = 0.004), valvular heart disease (29.4%, p = 0.00001), and atrial fibrillation (29.4%, p = 0.005) in Group-C. Smoking and diabetes mellitus were strongly related to the male gender (p = 0.000001, p=0.002 respectively) and valvular heart disease to the female gender (p= 0.0002).
Conclusions Awareness of risk factors and lifestyle modifications may have a bearing on stroke prevention. Cardiovascular risk factors in young patients mandate the need for robust prevention and screening.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of SMT. NHL Municipal Medical College gave Ethical Approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email Address:- amrita.parikh872{at}gmail.com
Email Address:- yagnya1699{at}gmail.com
Email Address:- devhdesai01{at}gmail.com
Email Address:- amiprakashvir{at}gmail.com
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.